Comprehensive evaluation of the humoral immune response to Coxiella bumetii may identify highly needed diagnostic antigens and potential subunit vaccine candidates. Here we report the construction of a protein microarray containing 1901 C. bumetii ORFs (84% of the entire proteome). This array was probed with Q-fever patient sera and naive controls in order to discover C. bumetii-specific seroreactive antigens. Among the 21 seroreactive antigens identified, 13 were significantly more reactive in Q-fever cases than naive controls. The remaining eight antigens were cross-reactive in both C. bumetii infected and na1ve patient sera. An additional 64 antigens displayed variable seroreactivity in Q-fever patients, and underscore the diversity of the humoral immune response to C. bumetii. Nine of the differentially reactive antigens were validated on an alternative immunostrip platform, demonstrating proof-of<oncept development of a consistent, safe, and inexpensive diagnostic assay alternative. Furthermore, we report here the identification of several new diagnostic antigens and potential subunit vaccine candidates for the highly infectious category B alphaproteobacteria, C. bumetii.
Introduction
Coxiella burnetii is a gram-negative, obligate intracellular bacteria, and the etiological agent of Q fever [1 ] . Distribution of C. burnetii is global, with infections occurring in a variety of mammals, birds, reptiles, fish, and ticks [2] . Sheep, goats, and other livestock are the primary reservoirs of C. bumetii.
However, infection of domesticated pets has also been noted. Coxiella infection of these animals is usually and the infection may be asymptomatic in half of infected patients. Symptoms of acute Q fever are often broad and include prolonged high fever, severe headache, confusion, vomiting, diarrhea, and malaise resulting in a 1-2% mortality rate. Chronic Q fever develops in 0.2% of infections, and can be fatal if left untreated. Current advances in treabnent (including the combination of doxycycline/ hydroxychloroquine) have successfully limited the mortality rate for Chronic Q fever to less than 1% [1, 4, 5] . Chronic infections may cause life-threatening endocarditis but may not show apparent symptoms, leading to under-reporting. The occurrence of both acute and chronic disease in humans has been linked to predisposing host factors [6, 7] . Current diagnosis of Q fever is based on several methods of detection including: indirect immunoperoxidase assay [8] , ELISA [9-11), monoclonal antibodies for paraffin-embedded tissues (12], PCR-based assays [13] , microagglutination [14, 15] , complement fixation test, and indirect immunofluorescence assay. The latter two are the only commercially available diagnostic assays and require purified phase I and phase II organisms as antigens. Since production of whole organisms is difficult and hazardous, there is an imperative need for alternative serodiagnostic reagents, including recombinant proteins. Typically, recombinant protein-based diagnostic assays have less inconsistency than whole-cellbased assays, and increased specificity. However, the serodiagnostic antigens of C. bumetii have not been well characterized on a comprehensive proteomic level, and warrant thorough investigation.
High-density proteome microarrays offer an effective means for determining the complete antigen-specific antibody response to infection on a genome-wide scale [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . Unlike 2-DE, protein microarrays can be fabricated in large numbers so that individual patient specimens can be conveniently and quantitatively interrogated, enabling a more complete understanding of the extent and diversity of the host response to infection on a patient-specific and antigenspecific basis, across the complete proteome. Vaccine and serodiagnostic antigens against several infectious agents have been discovered in this way [16, 20, 22, 24) . For these reasons a first generation C. bumetii proteome microarray was fabricated using transcriptionally active PCR (TAP) fragments, probed with a small collection of Q-fever patient specimens (n = 5), and a set of seroreactive antigens were identified [18) .
Beare et al. [18] then cloned the identified antigens into expression plasmids and directly compared microarrays containing proteins expressed in in vitro transcription-translation (IVIT) reactions from plasmids to TAP fragments.
Beare et al. (18) concluded increased reactivity in plasmiddriven IVTf expressed proteins. In this report we have cloned the complete proteome into expression plasmids and fabricated a comprehensive C. bumetii proteome array produced entirely (1901 ORFs) from the plasmid based expression system and probed with a large collection of patient (n = 40) and control sera (n = 20). Furthermore, we identified a set of differentially reactive and cross-reactive antigens, and vali-dated the diagnostic potential of these antigens using an alternative Western-blot style im.munostrips platform (also called line blots).
Materials and methods

PCR amplification of linear acceptor vector
ORFs were cloned into pXT7 vector using a high-throughput PCR cloning method previously described [21 ] . pXT7 plasmid (3.2 kb, KanR) encoding an N-terminal 10 x histidine (HIS) tag and a C-terminal hemagglutinin (HA) tag was linearized with BamHI (0.1!-lg/llL DNA, 0.1 mgfmL BSA, 0.2 UfllL BamHI. Invitrogen) overnight at 37°C. The digest was purified using PCR purification kit (Qiagen, Valencia, CA, USA), quantified using a NanoDrop (Thermo Scientific), and verified by agarose gel electrophoresis. PCR was used to generate the linear acceptor vector in 50 J.!L PCRs with 0.5 J.!M of each primer (CTACCCATACGATGTTCCGGATTAC and CTC-GACATATGCTTGTCGTCGTCG). PCR was performed using 0.02 U/J.ll AccuPrime Taq DNA polymerase (Invitrogen), 0.8 mM dNTPs, and 1 ng pXT7 diluted in AccuPrime Buffer II using the following conditions: 95oc for 5 min 30 cycles of 95°C for 0.5 min, SO"C for 0.5 min, 72°C for 3.5 min, and a final extension of 7rC for 10 min.
ORF cloning
All C. bumetii (AE016828) ORFs larger than 150bp were attempted to be cloned using 20 bp ORF sequence-specific PCR primers to the 5' and 3' ends. A unique 20 bp homologous recombination "adapter" sequence was included on the end of the 5' and 3' ORF specific primers (ACGA-CAAGCATATGCTCGAG and TCCGGAACATCGT-ATGGGTA, respectively). The adapter sequences, which become incorporated into the termini flanking the amplified gene, are homologous to the cloning sites of the linearized T7 expression vector pXT7 and allow for high-throughput cloning without the need for restriction or ligase enzymes. PCRs were prepared using 0.02 U/J.!L AccuPrime Taq DNA polymerase (Invitrogen), 0.8 mM dNTPs, diluted in Buffer II, with 2.5 ng of C. bumetii template with the following conditions: 95°C for 2 min, 30 cycles of 95°C for 0.33 min, SS"C for 0.25 min, sooc for 0.25 min, 68°C for 3 min, and a final extension of 68°C for 10min. All C. bumetii ORF-PCRs were confirmed by gel electrophoresis for correct insert size prior to cloning into pXT7.
High-throughput recombination cloning
Linearized pX17 was diluted to 10 ng/J.I.L, mixed with 1 J.I.L of C. burnetii ORF PCR mixture at a volume ratio of 4:1, and incubated on ice for 2 min, followed by addition of 10 J.!L of www.proteomics-joumal.com competent DHSa. cells. Reactions were mixed, incubated on ice for 30 min, heat shocked at 42°C for 1 min, and chilled on ice for 2 min. Aliquots of 250 J.lL of SOC media were added and cells were incubated for 1 h at 37°C. The whole reaction mixtures were added to 1.5 mL of LB medium with 50 J.lg/mL of kanamycin, and incubated overnight at 37°C with shaking. Plasmids were isolated using QIAprep 96 Turbo kits (Qiagen) without colony selection. Minipreps of all 2078 attempted clones were analyzed by agarose gel electrophoresis to confirm insert size. Ninety-five percent of all clones were confirmed for insert size by PCR using ORF sequence-specific primers. An additional 25% of all clones were selected at random and sequenced in both directions. Sequences were analyzed for fidelity, orientation, and for mutation in the overlapping region of the homologous recombination sites.
Protein microarray chip printing
The expressions of cloned ORFs were carried out for 5 h in IVIT reactions (RTS 100 kits from Roche) according to the manufacturer's instructions. Protein microarrays were printed onto nitrocellulose coated glass FAST slides (Whatman) using an Omni Grid 100 microarray printer (Genomic Solutions). Aliquots of 3.3 J.lL of 0.2% Tween-20 were mixed with 10 J.lL of IVIT and transferred to 384-well plates. Plates were centrifuged at 1600 x g to pellet any precipitate and remove air bubbles prior to printing. Supernatants were printed immediately without purification, and all ORFs were spotted in duplicate. Data values reported herein represent average of the pair, unless otherwise mentioned. In addition each chip was printed with control spots consisting of IVIT reaction without plasmid, purified Vaccinia immune globulin, and purified EBNA1 protein. Vaccinia immune globulin and EBNA1 were obtained from ADi as a gift and printed 16 times in serial dilution on each microarray and can be seen on the representation microarray images in Fig. 1 . Protein expression was confirmed by using monoclonal anti-poly-HIS (clone HIS-1, Sigma) and anti-HA (done 3F10, Roche).
Microarray probing
Thirty-two Q-fever patient sera from Australia (Dr. John Stenos, Australian Rickettsial Reference Laboratory, Geelong Hospital, Geelong VIC 3220) were acquired through approved exempt protocol NMRC.2008.0006. Samples were collected with IRB approval during outbreaks. All specimens are stored without identifiers and the identity of the individual patients cannot be ascertained. Sera were obtained from eight US soldiers whose clinical presentations were characterized by rapid onset of fever and chills. After washing the slides three times in TTBS, bound antibodies were detected by incubation with streptavidin-conjugated SureLight® P-3 (Columbia Biosciences). The slides were then washed three times in TTB S and three times in Tris buffer without Tween-20 followed by a final water wash. The slides were air dried after brief centrifugation and analyzed using a Perkin Elmer ScanArray Express HT microarray scanner.
lmmunostrip assay
Twenty ORFs from sequence-confirmed plasmids were expressed in 5 h IVIT reactions according to the manufacturer's instructions. Proteins were printed on Optitran BA-S 85 0.45 J.lm nitrocellulose membrane (Whatman) using BioJet dispenser (BioDot) at 1 J.lL/cm. and cut into 3 mm strips. Individual strips were then blocked for 30 min in 10% nonfat dry milk dissolved in TTBS. Prior to immunostrip probing, sera was diluted to 1/250 in 10% nonfat dry milk solution containing E. coli lysate at a final concentration of 20%vjv and incubated for 30min with constant mixing at room temperature. Pre-treated sera were then applied to each strip and incubated overnight at 4 oc with gentle mixing. Strips were washed five times in TTBS, and then incubated for 1 h at room temperature in alkaline phosphatase conjugated donkey anti-human immunoglobulin (anti-IgG, Fey fragment-specific, Jackson Immuno Research), which was diluted to 1/5000 in TTBS. The strips were then washed three times in TTBS, followed by another three washes in tris buffer without Tween-20, and reactive bands were visualized by incubating with 1-step NBTJBCIP developing buffer (Thermo Fisher Scientific) for 2.5 min at room temperature. The enzymatic reaction was stopped by washing the strips with tap water. Strips were air dried and scanned at 2400 dpi (Hewlett-Packard scanner). Images were converted to gray scale format by Photoshop. Unaltered images are shown. Proteins were printed in d uplicates and each array contains positive lgG control spots printed from six serial di lutions of hu man lgG, six serial di lutions of EBNA 1 protein, and six "No DNA" negative control spots. The array was probed with anti-HIS (A) and anti-HA (8 ) antibody as described in Section 2 to confirm the protein expression and spot reproducibility. Representative protein microa rray images of uninfected (C) and infected (D). The arrays were read in a laser confocal scanner and t he data normalized as described in Section 2. The signal intensity of each antigen is represented by rainbow palette of blue, green, red, and w hite by increasing signal intensity. Arrays were probed w ith 40 0-fever and 20 control serum samples as described in Section 2.
Dat a and statistical analysis
Protein microarrays were scanned and analyzed using a Perkin Elmer ScanArray Express HT microarray scanner. Intensities are quantified using QuantArray M icroarray Analysis software. All signal intensities are automatically corrected for spot-specific background. Proteins are considered to be expressed if either tag's signal intensity is greater than the average signal intensity of the IVIT reaction without plasmid, plus 2.5 ti mes the standard deviation. "NoDNA" controls consisting of IVIT reactions without addition of plasmid were averaged and used to subtract background reactivity from the unmanipulated raw data. 
Results
Gene amplification and cloning
The proteome of C. bumetii strain RSA 493 was cloned using a high-throughput PCR recombination cloning method developed in our laboratory [21] . Custom PCR primers comprising 20 bp of gene-specific sequence with 20 bp of "adapter" sequences are used in PCRs with genomic DNA as template. The adapter sequences were designed to be homologous to the cloning site of the linearized T7 expression vector pXT7, which allowed the PCR products to be cloned by homologous recombination and transformation into Escherichia coli DHSC£ cells. The C. burnetii ORFs were amplified using primers designed to done all 2077 ORFs in the C. burnetii genome larger than 50 amino acids in length. One ORF (CBU0231) was split into two segments based on its length and therefore 2078 cloning reactions were performed. Of the 2078 cloning reactions 1974 were successful (including both segments of CBU0231). All clones were verified for presence of insert by gel electrophoresis and 955 out of those clones were confirmed for insert using ORF-specific primers in PCRs. Twenty-five percent of the cloned ORFs were selected at random and sequenced in both directions to verify target sequence match, orientation, and presence of mutations in the homologous overlapping region during homologous recombination. In >99% of the sequences, the correct insert was verified.
Construction of a C. burnetii protein microarray
C. bttmetii ORFs cloned into the pXT7 vector were expressed under the T7 promoter in a 5 h E. coli based cell-free IVIT reaction according to manufacturer's instructions. Proteins were printed using an Omni Grid 100 microarray printer (Genomic Solutions) and analyzed for fluorescence on a Perkin Elmer ScanArray Express HT microarray scanner. Proteins were printed in duplicate and evaluated for expression. JVIT expression efficiency was determined by probing against the amino-terminal H IS and carboxy-terminal HA tags for each spot (Fig. lA and B) . Anti-HIS (done 
Profile of humoral response in Q-fever p at i ent and na' ive controls
Characteristic profiles of antigen reactivity were distinct between Q-fever patients and na'ive controls. Seroreactive antigens that are specifically reactive with Q-fever sera but not na'ive sera are considered serodiagnostic (p-value 5 0.05). Antigens that are not significantly differentially reactive are cons idered cross-reactive (p-value >0.05). Crossreactive antigens may react strongly in Q-fever patients, but are similarly reactive in na'ive controls. In contrast, seroreactivity to serodiagnostic antigens is significantly lower in the na'ive controls than in C. bumetii infected patients. Of the 21 seroreactive antigens. a distinguishing set of 13 serodiagnostic antigens, and eight cross-reactive antigens were identified between infected and na'ive groups (Fig. 2) . Sera in Fig. 3 were sorted from left to right by increasing average seroreactivity. Ali seroreactive antigens are grouped as either serodiagnostic or cross-reactive and are sorted in rows with the most reactive antigen to the Q-fever group listed fi rst (C BU1910 and CBU 1627. respectively), and the least reactive antigen last (CB U0653 and CBU0436, respectively). The average reactivity of each antigen was compared between the C. b~1metii infected and na'ive samples (Fig. 3) . These results showed that many antigens that were not considered seroreactive (on average) were highly reactive for some Q-fever or na'ive individual sera (Supporting Information Table 1 ). While these antigens do not meet our criteria of seroreactivity, they may provide additional insight into the variability of individual humoral immune responses to C. burneti, which may be easily overlooked by other by other methodologies examining pooled patient samples. The variable immune response we observed is also to be expected in an outbred human population. T he patient samples are in columns and are soned left to right by increasing average serodiagnostic antigen intensity.
A. Vi gil et a/.
Proteo m ic features of seroreactive antigens
The repertoire of antigen-specific reactivity to C. bw11etii is shown in Table 1 . The data in Table 1 summarize the proteomic fea tures of the 13 serodiagnostic antigens and eight cross-reactiv~ antigens. Eight of the serorcactive antigens contain a signal peptide, and of those, two are predicted to be localized to the outer membrane using SignalP v3.0 and PSORTb v2.0.4 computation software. respectively (both outer membrane proteins were found in the serodiagnostic set). Five serodiagnostic and six crossreactive antigens are predicted to contain at least one transmembrane domain based on the TMHMM v2.0 computational prediction software [3 1. 32] . Of the 2272 ORFs in the entire proteome. 1746 do not contain a predicted transmembrane domain, 218 contain a single transmembrane domain, and 308 contain two or more transmembrane domains. The significant enrichment of seroreactive proteins containing predicted transmembrane domains (Fisher Exact p-value = 3.2 x 10-3 ) is expected and was observed in a previous protein microarray against Burkholderia psuedomallei [16] .
lmmunostrip validation and sero diagnosis
To validate the protein microarray seroreactivity and to test the feasibility of transferring these serodiagnostic antigens to an alternative and potentially universal platform. 20 clones were selected, including ten seroreactive antigens (Fig. 4) . All 20 clones were single colony purified and sequenced for correct insert in -both directions. I mmunostrips included a standard curve of human IgG antibody for enzymatic developing consistency. Antigens were expressed in a 5 h IVTT reaction and were printed using a Biojet dispenser. Immunostrips were probed with the entire Proteomics 2010, 70, 2259-2269 collection of sera, and developed as described in Section 2. Reactive bands were visualized after incubation with alkaline phosphatase con jugated anti-human secondary antibody, fo llowed by substrate, and scanned using a desktop scanner at 2400 dpi (H ewlett-Packard scanner). Images were converted to grayscale fo rmat and unaltered images of representative immunostrips are shown in Fig. 4 . In Fig. 4 , clear and distinct reactive bands can be visualized in C. burnetii infected sera compared with na'ive samples. Ten antigens that did not show seroreactivity by protein microarray were printed as negative controls and did not result in detectable signal on the immunostrip. as expected. Further assessment of the diagnostic accuracy with the immunostrip platform (and e>.isting commercial diagnostic assays) will be made using a blinded and appropriate collection of sera samples.
Discussion
In this study we have constructed a C. burnetii protein microarray to interrogate the humoral immune response to Q fever. The proteome array was probed in high-throughput fashion against 84% of the C. bttrnetii proteome in order to profile the human humoral immune response to infection. In this manner we were able to defi ne the seroreactive response to Q-fe ver infection , includin g the identification of 13 serodiagnostic antigens. Nine of these serodiagnostic antigens were tested in a proof-of-principle diagnostic assay, and may have potential in further development of C. burnetii diagnostic assays or as vaccine candidates. Use of immunostrips as an alternative platform validated the serareactivity we found in the microarrays and may provide an inexpensive and simple alternative to current diagnostics. Further investigation of this diagnostic platform and others (e.g. ELISA) will need to be carried out using a traditional Q fever blinded study with an appropriate collection of sam ples to determine sensitivity and specificity.
We have previously reported the seroreactivity of five of the 21 seroreactive proteins using a TAP based protein microarray (18] . The TAP system utilizes a T7 promoter containing PCR product as templates for IVIT reaction. Beare et al. identified 44 seroreactive ORFs using 5 individual sera samples. The 44 reactive ORFs discovered using the TAP-based m icroarray were then compared with the same ORFs cloned into an expression plasm id driven IVIT reaction. Beare c:t al. concluded that protein expression is more efficient in plasmid-driven IVIT than from TAP template-driven reactions, and that detection of seroreactivity was significantly more sensitive when using the plasm id-based IVIT reactions [18] . Because of this earlier work, we developed an expression plasmid-based microarray of all C. bumetii ORFs larger than 50aa to comprehensively interrogate tl1e humoral immune response to Q fever. We expected that using the plasmid-based m icroarray we would have higher sensitivity in detecting antibody response than the TAP-based microarray. As expected, we found that only highly reactive antigens were able to be previously identified. These five antigens (CBU0891, CBU1143. CBU0612, CBU0545, and CBU1398) were tl1e five most reactive antigens using the TAP system. These results support the conclusions by Beare et al., which found that the sensitivity Serodiagnostic antigens were printed onto n itrocellulose paper in adjacent stripes usi ng a BioDot jet dispenser. Antigens that were discovered to be serodiagnostic by p rotein microarray are indicated by an asterisk. Human lgG was printed on the bottom in serial di lution as a control. Image shows representa· tive strip s for infect ed and na'ive hu man sera samples as well as two strips probed in parallel with secondary antibody only.
for seroreactivity of the TAP-based system may indeed be lower tha n the plasmid-based system. In addition to the antigens discovered by Beare et al. , we identify an additional eight serodiagnostic proteins along with all eight crossreactive proteins.
CBU 1910 (Coml ), an outer membrane protein. was the most seroreactive antigen, as well as the most significant differentially reactive antigen (p-value = 5 x 10-8 ) . This antigen has been reported to be targeted by the early humoral immune response in vaccinated cattle [33] , and in acutely infected guinea pigs of the Nine Mile strain in phase I [34] . ELISA-based assays using CBU1910 were able to distinguish vaccinated cattle from those naturally exposed [33 ] . Moreover. CBU1910 vaccinated humanized mice (HLA-DR4 transgenic) have recently been shown to induce a strong y interferon recall response in purified CD4 + T cells [35] , consistent with the link between T-helper-cell-mediated antibody response. As previously reported, this antigen was not discovered by the TAP system, due to poor expression from tl1e TAP IVIT reaction system ]18]. Nonetheless, Beare et at. found that IVIT expressed CB U191 0 utilized in a diagnostic ELISA assay had higher specificity than C. bumetii cell extract (specifi city ;sensitivity of 90.0/50.0 compared with 87.5/ 85.0, respectively) [18] . CBU0891, a hypothetical protein, was the second most reactive protein in our assay. It was the most reactive protein identified by the TAP system, again showing consistency with previous results. CBU0891 contains a predicted signal peptide by SingalP, but has unknown predicted cellular localization by PSORTb. Further characterization of this protein may provide insight into the reasons why the human humoral immune response targets this antigen to such a high degree. CBU1143 (YajC) was the fourth most reactive antigen and was also previously identified as serodiagnostic by the TAP microarray. YajC contains a predicted signal peptide and is localized to the inner membrane. YajC is also found to be involved in Sec-dependent secretion [36] and is both a B<ell and T<ell antigen in Brucella abortus [37] . We did not find reactivity to this antigen from Brucella melitensis infected human sera (Fig. 3) . This is likely due to the low sequence homology (39%) between C. burnetii strain 493 and the two Brucella species (B. abortus strain 2308 and B. melitensis strain 16M, which share 100% amino acid identity for YajC).
CBU0612 (OmpH) was identified by both microarrays. It contains a signal peptide, is predicted to be localized to the outer membrane by PSORTb, and is reported to be membrane associated [38) . It is one of two outer-membrane predicted that was found to be serodiagnostic. The other outer-membrane predicted protein is CB U0630 (Mip). A partially purified CBU0630 protein was more efficacious in enhancing clearance of organisms from spleens of infected mice than from other proteins or lipopolysaccharide [39] . CBU0109 (the third most reactive antigen), CBU0092, CBU0630, CBU1513, CBU1719, CBU0229, and CBU0653 were not previously identified by the TAP protein microarray and represent novel serodiagnostic antigens.
Additionally, we discovered eight antigens that were cross-reactive among Q-fever, nai've patient, and other bacteremia patient sera. None of these antigens were previously identified by the TAP protein microarray and are presumably the result of humoral response to similar protein structures derived from other unrelated bacterial infections. Furthermore, 64 C. burnetii proteins were significantly highly reactive (greater than four times the standard deviation of NoDNA control) to two or more individual Q-fever patient sera and present a variable distribution of reactivity. Of these 64 proteins, 31 were also seroreactive to one or more nai've sera. While the remaining 33 antigens were only seroreactive in the Q-fever sera collection, they did not serve as diagnostic markers, and may represent unique (or limited) immune responses to infection by C. burnetii. We listed all 64 of these antigens in the Supporting Information Table 1 . Further examination of these antigens may provide novel insight into pathogenesis and the diversity of immune response.
In this comprehensive investigation of the antibody response to the C. burnetii proteome, we have found that the seroreactive repertoire targeted only a small percentage of total bacterial proteome (1.00;6). Furthermore, a report by Zhang et al. indicates that the predominant IgG antibody response to phase I organisms recognized proteins and not lipopolysaccharide (40) . Together, these findings suggest that indeed the immunoreactive response to Q fever is very limited. While inclusion of a collection of 40 Q-fever patient samples allowed us to identify many seroreactive antigens, the total number of seroreactive antigens was relatively small and did not present a single universal common proteomic feature. Only 11 of the 21 seroreactive antigens contained a signal peptide, ten contained transmembrane domains, and four were predicted to have membrane localization. Titis is in marked contrast with the percentage of predicted signal peptide (9.5%) and transmembrane domain containing proteins (23.2%) in the entire proteome. The bias for signal peptide containing proteins was previously observed in a protein microarray screen of F. tularensis [22, 26] and B. pseudomallei [16) . While the humoral immune response to infection is not stochastic, in silico prediction of the antigenic profile based on sequence data alone is still imperfect. We have found that the majority of proteins containing predictive features are mainly nonreactive, and importantly many seroreactive proteins do not contain predictive proteomic features for seroreactivity. For example, six of the 21 seroreactive antigens (28%) identified here do not contain transmembrane domains or signal peptides, and have unknown or cytoplasmic predicted subcellular location. These molecules are unlikely to be predicted by in silico prediction algorithms. The results presented here highlight the necessity for empirical determination of seroreactivity and improved in silica prediction algorithms for antigen discovery, vaccine development, and insight into the humoral immune response and antigenicity of bacterial pathogens. Currently, the only vaccine against C. burnetii infection is a killed cellular vaccine (Q-Vax), which is licensed in Australia (41] and there is no Food and Drug Administration-approved vaccine for human or animal use in the United States, as well as in most countries.
Vaccination causes severe local and occasional systemic reaction in patients sensitized to C. burnetii and requires a skin test prior to vaccination (42] . Protection against Q fever is reported to involve both cellular and humoral immunity [43] . Successful demonstration of Q-fever vaccination using recombinant proteins has been reported [44--46] . Development of subunit vaccines and improved diagnostic tests that do not rely on hazardous production of whole<ell bacteria is needed. We believe that the comprehensive evaluation of the humoral immune response to C. burnetii reported here may provide additional diagnostic tools and valuable identification for potential subunit vaccine candidates. Comprehensive evaluation of the humoral inunune response to Q fever is necessary for novel insight into pathogenesis, as well as the development of subunit vaccines and diagnostics based on recombinant proteins.
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